The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese
© 2022 European Academy of Neurology..
BACKGROUND AND PURPOSE: Recent genetic progress has shown many causative/risk genes linked to Parkinson's disease (PD), mainly in patients of European ancestry. The study aimed to investigate the PD-related genes and determine the mutational spectrum of early-onset PD in ethnic Chinese.
METHODS: In this study, whole-exome sequencing and/or gene dosage analysis were performed in 704 early-onset PD (EOPD) patients (onset age ≤45 years) and 1866 controls. Twenty-six PD-related genes and 20 other genes linked to neurodegenerative and lysosome diseases were analysed.
RESULTS: Eighty-two (11.6%, 82/704) EOPD patients carrying rare pathogenic/likely pathogenic variants in PD-related genes were identified. The mutation frequency in autosomal recessive inheritance EOPD (42.9%, 27/63) was much higher than that in autosomal dominant inheritance EOPD (0.9%, 12/110) or sporadic EOPD (8.1%, 43/531). Bi-allelic mutations in PRKN were the most frequent, accounting for 5.1% of EOPD cases. Three common pathogenic variants, p.A53V in SNCA, p.G284R in PRKN and p.P53Afs*38 in CHCHD2, occur exclusively in Asians. The putative damaging variants from GBA, PRKN, DJ1, PLA2G6 and GCH1 contributed to the collective risk for EOPD. Notably, the protein-truncating variants in CHCHD2 were enriched in EOPD, especially for p.P53Afs*38, which was also found in three patients from an independent cohort of patients with late-onset PD (n = 1300). Functional experiments confirmed that truncated CHCHD2 variants cause loss of function and are linked to mitochondrial dysfunction.
CONCLUSIONS: Our study reveals that the genetic spectrum of EOPD in Chinese, which may help develop genetic scanning strategies, provided more evidence supporting CHCHD2 in PD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
European journal of neurology - 29(2022), 11 vom: 18. Nov., Seite 3218-3228 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Yong-Ping [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Burden analysis |
|---|
| Anmerkungen: |
Date Completed 10.10.2022 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ene.15509 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343814056 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343814056 | ||
| 003 | DE-627 | ||
| 005 | 20231226021322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ene.15509 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM343814056 | ||
| 035 | |a (NLM)35861376 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Yong-Ping |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.10.2022 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 European Academy of Neurology. | ||
| 520 | |a BACKGROUND AND PURPOSE: Recent genetic progress has shown many causative/risk genes linked to Parkinson's disease (PD), mainly in patients of European ancestry. The study aimed to investigate the PD-related genes and determine the mutational spectrum of early-onset PD in ethnic Chinese | ||
| 520 | |a METHODS: In this study, whole-exome sequencing and/or gene dosage analysis were performed in 704 early-onset PD (EOPD) patients (onset age ≤45 years) and 1866 controls. Twenty-six PD-related genes and 20 other genes linked to neurodegenerative and lysosome diseases were analysed | ||
| 520 | |a RESULTS: Eighty-two (11.6%, 82/704) EOPD patients carrying rare pathogenic/likely pathogenic variants in PD-related genes were identified. The mutation frequency in autosomal recessive inheritance EOPD (42.9%, 27/63) was much higher than that in autosomal dominant inheritance EOPD (0.9%, 12/110) or sporadic EOPD (8.1%, 43/531). Bi-allelic mutations in PRKN were the most frequent, accounting for 5.1% of EOPD cases. Three common pathogenic variants, p.A53V in SNCA, p.G284R in PRKN and p.P53Afs*38 in CHCHD2, occur exclusively in Asians. The putative damaging variants from GBA, PRKN, DJ1, PLA2G6 and GCH1 contributed to the collective risk for EOPD. Notably, the protein-truncating variants in CHCHD2 were enriched in EOPD, especially for p.P53Afs*38, which was also found in three patients from an independent cohort of patients with late-onset PD (n = 1300). Functional experiments confirmed that truncated CHCHD2 variants cause loss of function and are linked to mitochondrial dysfunction | ||
| 520 | |a CONCLUSIONS: Our study reveals that the genetic spectrum of EOPD in Chinese, which may help develop genetic scanning strategies, provided more evidence supporting CHCHD2 in PD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a CHCHD2 | |
| 650 | 4 | |a Parkinson's disease | |
| 650 | 4 | |a burden analysis | |
| 650 | 4 | |a mutation spectrum | |
| 650 | 7 | |a CHCHD2 protein, human |2 NLM | |
| 650 | 7 | |a DNA-Binding Proteins |2 NLM | |
| 650 | 7 | |a Transcription Factors |2 NLM | |
| 700 | 1 | |a Yu, Shi-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Guo-Hui |e verfasserin |4 aut | |
| 700 | 1 | |a Hou, Yan-Bing |e verfasserin |4 aut | |
| 700 | 1 | |a Gu, Xiao-Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Ou, Ru-Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Xue-Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Bi |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Bei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ling-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Ming-Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Fei-Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Qian-Qian |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Kun-Cheng |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Jun-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Tian-Mi |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Zheng |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Jiao |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Yang-Fan |e verfasserin |4 aut | |
| 700 | 1 | |a Xiao, Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Su, Wei-Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Fei |e verfasserin |4 aut | |
| 700 | 1 | |a Cai, Ying-Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Shi-Rong |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Tao |e verfasserin |4 aut | |
| 700 | 1 | |a Yuan, Xiao-Qin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Qing-Qing |e verfasserin |4 aut | |
| 700 | 1 | |a Shao, Na |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Sha |e verfasserin |4 aut | |
| 700 | 1 | |a Shang, Hui-Fang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of neurology |d 1994 |g 29(2022), 11 vom: 18. Nov., Seite 3218-3228 |w (DE-627)NLM094480362 |x 1468-1331 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2022 |g number:11 |g day:18 |g month:11 |g pages:3218-3228 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ene.15509 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2022 |e 11 |b 18 |c 11 |h 3218-3228 | ||